|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
61,456,000 |
Market
Cap: |
1.04(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$13.01 - $33.99 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile CareDx together with its subsidiaries, is a medicine company focused on the discovery, development and commercialization of diagnostic solutions for transplant patients and caregivers. Co. provides testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey, and is a provider of genomics-based information for transplant patients. Co.'s commercially available testing services consist of AlloSure® Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients, AlloMap® Heart, a solution for heart transplant patients, AlloSure® Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure® Lung.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
112,994 |
118,423 |
260,986 |
299,796 |
Total Sell Value |
$1,880,845 |
$2,012,516 |
$6,621,587 |
$6,981,114 |
Total People Sold |
6 |
6 |
7 |
8 |
Total Sell Transactions |
8 |
10 |
17 |
26 |
End Date |
2025-03-04 |
2024-12-01 |
2024-06-02 |
2023-06-03 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hagstrom William A |
|
|
2025-05-28 |
4 |
S |
$17.45 |
$523,413 |
D/D |
(30,000) |
53,979 |
|
- |
|
Hagstrom William A |
|
|
2025-05-28 |
4 |
OE |
$4.95 |
$223,441 |
D/D |
30,000 |
83,979 |
|
- |
|
Jain Abhishek |
Chief Financial Officer |
|
2025-05-27 |
4 |
D |
$17.63 |
$34,943 |
D/D |
(1,982) |
327,412 |
|
- |
|
Cournoyer Christine |
Director |
|
2025-05-12 |
4 |
S |
$15.96 |
$465,022 |
D/D |
(29,136) |
37,045 |
|
-1% |
|
Cournoyer Christine |
Director |
|
2025-05-12 |
4 |
OE |
$7.96 |
$231,923 |
D/D |
29,136 |
66,181 |
|
- |
|
Cournoyer Christine |
Director |
|
2025-05-06 |
4 |
S |
$14.13 |
$235,929 |
D/D |
(16,700) |
37,045 |
|
-17% |
|
Novack Jeffrey Adam |
Secretary and General Counsel |
|
2025-05-05 |
4 |
AS |
$14.70 |
$39,514 |
D/D |
(2,688) |
121,350 |
|
12% |
|
Jain Abhishek |
Chief Financial Officer |
|
2025-05-01 |
4 |
D |
$15.07 |
$115,828 |
D/D |
(7,686) |
329,394 |
|
- |
|
Novack Jeffrey Adam |
Secretary and General Counsel |
|
2025-05-01 |
4 |
D |
$15.07 |
$43,296 |
D/D |
(2,873) |
124,038 |
|
- |
|
Maag Peter |
|
|
2025-04-30 |
4 |
AS |
$17.23 |
$228,796 |
D/D |
(13,281) |
316,743 |
|
1% |
|
Jain Abhishek |
Chief Financial Officer |
|
2025-04-21 |
4 |
D |
$16.94 |
$5,726 |
D/D |
(338) |
337,080 |
|
- |
|
Hanna John Walter Jr |
President & CEO |
|
2025-04-15 |
4 |
D |
$19.16 |
$1,177,746 |
D/D |
(61,469) |
627,041 |
|
- |
|
Novack Jeffrey Adam |
Secretary and General Counsel |
|
2025-04-07 |
4 |
S |
$17.72 |
$16,373 |
D/D |
(924) |
126,911 |
|
7% |
|
Jain Abhishek |
Chief Financial Officer |
|
2025-04-07 |
4 |
S |
$17.72 |
$4,696 |
D/D |
(265) |
337,418 |
|
7% |
|
Goldberg Michael |
Director |
|
2025-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
967 |
140,895 |
|
- |
|
Jain Abhishek |
Chief Financial Officer |
|
2025-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
55,580 |
337,683 |
|
- |
|
Meng Jessica |
Chief Commercial Officer |
|
2025-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
61,756 |
114,332 |
|
- |
|
Kennedy Keith |
Chief Operating Officer |
|
2025-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
77,195 |
147,296 |
|
- |
|
Novack Jeffrey Adam |
Secretary and General Counsel |
|
2025-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
23,158 |
127,835 |
|
- |
|
Hanna John Walter Jr |
President & CEO |
|
2025-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
200,706 |
688,510 |
|
- |
|
Bickerstaff George |
|
|
2025-03-10 |
4 |
S |
$18.36 |
$367,102 |
D/D |
(20,000) |
103,027 |
|
8% |
|
Jain Abhishek |
Chief Financial Officer |
|
2025-02-05 |
4 |
D |
$23.32 |
$232,943 |
D/D |
(9,989) |
282,103 |
|
- |
|
Jain Abhishek |
Chief Financial Officer |
|
2025-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
37,800 |
292,092 |
|
- |
|
Novack Jeffrey Adam |
Secretary and General Counsel |
|
2025-02-04 |
4 |
AS |
$23.30 |
$81,829 |
D/D |
(3,512) |
104,677 |
|
-26% |
|
Novack Jeffrey Adam |
Secretary and General Counsel |
|
2025-02-03 |
4 |
D |
$23.32 |
$47,759 |
D/D |
(2,048) |
108,189 |
|
- |
|
783 Records found
|
|
Page 1 of 32 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|